2003
DOI: 10.1038/sj.npp.1300267
|View full text |Cite
|
Sign up to set email alerts
|

Altered Serotonergic Neurotransmission but Normal Hypothalamic–Pituitary–Adrenocortical Axis Activity in Mice Chronically Treated with the Corticotropin-Releasing Hormone Receptor Type 1 Antagonist NBI 30775

Abstract: Antagonists of the corticotropin-releasing hormone receptor type 1 (CRH-R1) are regarded as promising tools for the treatment of stress-related psychiatric disorders. Owing to the intricate relationship between CRH and serotonin (5-HT), we studied the effects of chronic oral treatment of C57Bl6/N mice with the CRH-R1 antagonist NBI 30775 (formerly known as R121919) on hippocampal serotonergic neurotransmission during basal (on 15th day of treatment) and stress (forced swimming; on 16th day of treatment) condit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
30
0

Year Published

2005
2005
2013
2013

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 61 publications
(34 citation statements)
references
References 72 publications
(115 reference statements)
4
30
0
Order By: Relevance
“…infusion of CRF, Ucn1 or Ucn2 14,22,48,69 is effective at increasing immediate-early gene expression within caudal regions of the DRN. In addition, several stress paradigms, CRF and its related peptides and the use of CRFR1 antagonists cause different changes in levels of 5-HT and 5-HIAA in the terminal regions, [70][71][72][73][74][75][76] underscoring the role of CRF and CRFrelated peptides in the regulation of extracellular 5-HT levels under basal and stress conditions.…”
Section: Discussionmentioning
confidence: 99%
“…infusion of CRF, Ucn1 or Ucn2 14,22,48,69 is effective at increasing immediate-early gene expression within caudal regions of the DRN. In addition, several stress paradigms, CRF and its related peptides and the use of CRFR1 antagonists cause different changes in levels of 5-HT and 5-HIAA in the terminal regions, [70][71][72][73][74][75][76] underscoring the role of CRF and CRFrelated peptides in the regulation of extracellular 5-HT levels under basal and stress conditions.…”
Section: Discussionmentioning
confidence: 99%
“…All experiments were performed on day 1 after the insertion of the microdialysis probe between 06:00 and 12:00 h to avoid interference with rodents' physiologically rising corticosterone levels in the afternoon (Oshima et al, 2003).…”
Section: In Vivo Microdialysis Proceduresmentioning
confidence: 99%
“…In contrast, in vivo microdialysis enables continuous sampling of glucocorticoids at their respective receptors within the brain, and only the free and biological active fraction of the hormone is determined. However, this approach has only been used scarcely for the assessment of HPA axis activity in mutant mice or in response to pharmacological manipulations (e.g., Sillaber et al, 1998;Linthorst et al, 2000;Oshima et al, 2003;Keeney et al, 2006).…”
Section: Article In Pressmentioning
confidence: 99%
“…Similarly, an acute intracerebroventricular administration of CRH in rats has been shown to result in a dose-dependent increase in the levels of hippocampal 5-HT and its metabolite, 5-hydroxyindoleacetic acid, suggesting the involvement of CRH-R1 [162]. Lastly, Oshima and colleagues [163] have reported alterations in hippocampal serotonergic neurotransmission in rats treated chronically with NBI 30775, a CRH-R1 antagonist, which has antidepressant action. A molecular mechanism by which CRH and 5-HT might interact has been proposed recently by Magalhaes and colleagues [164].…”
Section: E Hpa-axis and Monoaminergic Systemsmentioning
confidence: 98%